Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Array-Based Exome Enrichment
1.2.3 Enrichment of the Exome in Solution using Biotinylated Probes
1.3 Market by Application
1.3.1 Global Clinical Whole Exome Sequencing (WES) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Rare Genetic Disease
1.3.3 Genetic Testing Unsuccessful
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Whole Exome Sequencing (WES) Market Perspective (2018-2033)
2.2 Clinical Whole Exome Sequencing (WES) Growth Trends by Region
2.2.1 Global Clinical Whole Exome Sequencing (WES) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Clinical Whole Exome Sequencing (WES) Historic Market Size by Region (2018-2023)
2.2.3 Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Region (2024-2033)
2.3 Clinical Whole Exome Sequencing (WES) Market Dynamics
2.3.1 Clinical Whole Exome Sequencing (WES) Industry Trends
2.3.2 Clinical Whole Exome Sequencing (WES) Market Drivers
2.3.3 Clinical Whole Exome Sequencing (WES) Market Challenges
2.3.4 Clinical Whole Exome Sequencing (WES) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Whole Exome Sequencing (WES) Players by Revenue
3.1.1 Global Top Clinical Whole Exome Sequencing (WES) Players by Revenue (2018-2023)
3.1.2 Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Whole Exome Sequencing (WES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Whole Exome Sequencing (WES) Revenue
3.4 Global Clinical Whole Exome Sequencing (WES) Market Concentration Ratio
3.4.1 Global Clinical Whole Exome Sequencing (WES) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Whole Exome Sequencing (WES) Revenue in 2022
3.5 Clinical Whole Exome Sequencing (WES) Key Players Head office and Area Served
3.6 Key Players Clinical Whole Exome Sequencing (WES) Product Solution and Service
3.7 Date of Enter into Clinical Whole Exome Sequencing (WES) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Whole Exome Sequencing (WES) Breakdown Data by Type
4.1 Global Clinical Whole Exome Sequencing (WES) Historic Market Size by Type (2018-2023)
4.2 Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Type (2024-2033)
5 Clinical Whole Exome Sequencing (WES) Breakdown Data by Application
5.1 Global Clinical Whole Exome Sequencing (WES) Historic Market Size by Application (2018-2023)
5.2 Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
6.2 North America Clinical Whole Exome Sequencing (WES) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023)
6.4 North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
7.2 Europe Clinical Whole Exome Sequencing (WES) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023)
7.4 Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
8.2 Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
9.2 Latin America Clinical Whole Exome Sequencing (WES) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023)
9.4 Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size (2018-2033)
10.2 Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CentoXome
11.1.1 CentoXome Company Detail
11.1.2 CentoXome Business Overview
11.1.3 CentoXome Clinical Whole Exome Sequencing (WES) Introduction
11.1.4 CentoXome Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.1.5 CentoXome Recent Development
11.2 Mayo Clinic Laboratories
11.2.1 Mayo Clinic Laboratories Company Detail
11.2.2 Mayo Clinic Laboratories Business Overview
11.2.3 Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Introduction
11.2.4 Mayo Clinic Laboratories Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.2.5 Mayo Clinic Laboratories Recent Development
11.3 Baylor Genetics
11.3.1 Baylor Genetics Company Detail
11.3.2 Baylor Genetics Business Overview
11.3.3 Baylor Genetics Clinical Whole Exome Sequencing (WES) Introduction
11.3.4 Baylor Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.3.5 Baylor Genetics Recent Development
11.4 Blueprint Genetics
11.4.1 Blueprint Genetics Company Detail
11.4.2 Blueprint Genetics Business Overview
11.4.3 Blueprint Genetics Clinical Whole Exome Sequencing (WES) Introduction
11.4.4 Blueprint Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.4.5 Blueprint Genetics Recent Development
11.5 GeneDx
11.5.1 GeneDx Company Detail
11.5.2 GeneDx Business Overview
11.5.3 GeneDx Clinical Whole Exome Sequencing (WES) Introduction
11.5.4 GeneDx Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.5.5 GeneDx Recent Development
11.6 CD Genomics
11.6.1 CD Genomics Company Detail
11.6.2 CD Genomics Business Overview
11.6.3 CD Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.6.4 CD Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.6.5 CD Genomics Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Clinical Whole Exome Sequencing (WES) Introduction
11.7.4 Illumina Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.7.5 Illumina Recent Development
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Detail
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher Clinical Whole Exome Sequencing (WES) Introduction
11.8.4 Thermo Fisher Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.8.5 Thermo Fisher Recent Development
11.9 Labassure
11.9.1 Labassure Company Detail
11.9.2 Labassure Business Overview
11.9.3 Labassure Clinical Whole Exome Sequencing (WES) Introduction
11.9.4 Labassure Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.9.5 Labassure Recent Development
11.10 Yale Medicine
11.10.1 Yale Medicine Company Detail
11.10.2 Yale Medicine Business Overview
11.10.3 Yale Medicine Clinical Whole Exome Sequencing (WES) Introduction
11.10.4 Yale Medicine Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.10.5 Yale Medicine Recent Development
11.11 Genosalut
11.11.1 Genosalut Company Detail
11.11.2 Genosalut Business Overview
11.11.3 Genosalut Clinical Whole Exome Sequencing (WES) Introduction
11.11.4 Genosalut Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.11.5 Genosalut Recent Development
11.12 Caris Life Sciences
11.12.1 Caris Life Sciences Company Detail
11.12.2 Caris Life Sciences Business Overview
11.12.3 Caris Life Sciences Clinical Whole Exome Sequencing (WES) Introduction
11.12.4 Caris Life Sciences Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.12.5 Caris Life Sciences Recent Development
11.13 InterGenetics
11.13.1 InterGenetics Company Detail
11.13.2 InterGenetics Business Overview
11.13.3 InterGenetics Clinical Whole Exome Sequencing (WES) Introduction
11.13.4 InterGenetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.13.5 InterGenetics Recent Development
11.14 Genomics and Pathology Services (GPS)
11.14.1 Genomics and Pathology Services (GPS) Company Detail
11.14.2 Genomics and Pathology Services (GPS) Business Overview
11.14.3 Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Introduction
11.14.4 Genomics and Pathology Services (GPS) Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.14.5 Genomics and Pathology Services (GPS) Recent Development
11.15 3billion
11.15.1 3billion Company Detail
11.15.2 3billion Business Overview
11.15.3 3billion Clinical Whole Exome Sequencing (WES) Introduction
11.15.4 3billion Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.15.5 3billion Recent Development
11.16 Broad Genomic
11.16.1 Broad Genomic Company Detail
11.16.2 Broad Genomic Business Overview
11.16.3 Broad Genomic Clinical Whole Exome Sequencing (WES) Introduction
11.16.4 Broad Genomic Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.16.5 Broad Genomic Recent Development
11.17 Roche
11.17.1 Roche Company Detail
11.17.2 Roche Business Overview
11.17.3 Roche Clinical Whole Exome Sequencing (WES) Introduction
11.17.4 Roche Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.17.5 Roche Recent Development
11.18 Novogene
11.18.1 Novogene Company Detail
11.18.2 Novogene Business Overview
11.18.3 Novogene Clinical Whole Exome Sequencing (WES) Introduction
11.18.4 Novogene Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.18.5 Novogene Recent Development
11.19 BGI Genomics
11.19.1 BGI Genomics Company Detail
11.19.2 BGI Genomics Business Overview
11.19.3 BGI Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.19.4 BGI Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.19.5 BGI Genomics Recent Development
11.20 Shanghai Jingzhou Genomics
11.20.1 Shanghai Jingzhou Genomics Company Detail
11.20.2 Shanghai Jingzhou Genomics Business Overview
11.20.3 Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.20.4 Shanghai Jingzhou Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.20.5 Shanghai Jingzhou Genomics Recent Development
11.21 Shihe Gene Biotechnology
11.21.1 Shihe Gene Biotechnology Company Detail
11.21.2 Shihe Gene Biotechnology Business Overview
11.21.3 Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Introduction
11.21.4 Shihe Gene Biotechnology Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.21.5 Shihe Gene Biotechnology Recent Development
11.22 JUNO Genomics
11.22.1 JUNO Genomics Company Detail
11.22.2 JUNO Genomics Business Overview
11.22.3 JUNO Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.22.4 JUNO Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
11.22.5 JUNO Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Array-Based Exome Enrichment
Table 3. Key Players of Enrichment of the Exome in Solution using Biotinylated Probes
Table 4. Global Clinical Whole Exome Sequencing (WES) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Clinical Whole Exome Sequencing (WES) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Clinical Whole Exome Sequencing (WES) Market Share by Region (2018-2023)
Table 8. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Clinical Whole Exome Sequencing (WES) Market Share by Region (2024-2033)
Table 10. Clinical Whole Exome Sequencing (WES) Market Trends
Table 11. Clinical Whole Exome Sequencing (WES) Market Drivers
Table 12. Clinical Whole Exome Sequencing (WES) Market Challenges
Table 13. Clinical Whole Exome Sequencing (WES) Market Restraints
Table 14. Global Clinical Whole Exome Sequencing (WES) Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Clinical Whole Exome Sequencing (WES) Market Share by Players (2018-2023)
Table 16. Global Top Clinical Whole Exome Sequencing (WES) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Whole Exome Sequencing (WES) as of 2022)
Table 17. Ranking of Global Top Clinical Whole Exome Sequencing (WES) Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Clinical Whole Exome Sequencing (WES) Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Clinical Whole Exome Sequencing (WES) Product Solution and Service
Table 21. Date of Enter into Clinical Whole Exome Sequencing (WES) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Type (2018-2023)
Table 25. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Type (2024-2033)
Table 27. Global Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Application (2018-2023)
Table 29. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Application (2024-2033)
Table 31. North America Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 46. CentoXome Company Detail
Table 47. CentoXome Business Overview
Table 48. CentoXome Clinical Whole Exome Sequencing (WES) Product
Table 49. CentoXome Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 50. CentoXome Recent Development
Table 51. Mayo Clinic Laboratories Company Detail
Table 52. Mayo Clinic Laboratories Business Overview
Table 53. Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Product
Table 54. Mayo Clinic Laboratories Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 55. Mayo Clinic Laboratories Recent Development
Table 56. Baylor Genetics Company Detail
Table 57. Baylor Genetics Business Overview
Table 58. Baylor Genetics Clinical Whole Exome Sequencing (WES) Product
Table 59. Baylor Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 60. Baylor Genetics Recent Development
Table 61. Blueprint Genetics Company Detail
Table 62. Blueprint Genetics Business Overview
Table 63. Blueprint Genetics Clinical Whole Exome Sequencing (WES) Product
Table 64. Blueprint Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 65. Blueprint Genetics Recent Development
Table 66. GeneDx Company Detail
Table 67. GeneDx Business Overview
Table 68. GeneDx Clinical Whole Exome Sequencing (WES) Product
Table 69. GeneDx Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 70. GeneDx Recent Development
Table 71. CD Genomics Company Detail
Table 72. CD Genomics Business Overview
Table 73. CD Genomics Clinical Whole Exome Sequencing (WES) Product
Table 74. CD Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 75. CD Genomics Recent Development
Table 76. Illumina Company Detail
Table 77. Illumina Business Overview
Table 78. Illumina Clinical Whole Exome Sequencing (WES) Product
Table 79. Illumina Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 80. Illumina Recent Development
Table 81. Thermo Fisher Company Detail
Table 82. Thermo Fisher Business Overview
Table 83. Thermo Fisher Clinical Whole Exome Sequencing (WES) Product
Table 84. Thermo Fisher Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 85. Thermo Fisher Recent Development
Table 86. Labassure Company Detail
Table 87. Labassure Business Overview
Table 88. Labassure Clinical Whole Exome Sequencing (WES) Product
Table 89. Labassure Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 90. Labassure Recent Development
Table 91. Yale Medicine Company Detail
Table 92. Yale Medicine Business Overview
Table 93. Yale Medicine Clinical Whole Exome Sequencing (WES) Product
Table 94. Yale Medicine Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 95. Yale Medicine Recent Development
Table 96. Genosalut Company Detail
Table 97. Genosalut Business Overview
Table 98. Genosalut Clinical Whole Exome Sequencing (WES) Product
Table 99. Genosalut Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 100. Genosalut Recent Development
Table 101. Caris Life Sciences Company Detail
Table 102. Caris Life Sciences Business Overview
Table 103. Caris Life Sciences Clinical Whole Exome Sequencing (WES) Product
Table 104. Caris Life Sciences Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 105. Caris Life Sciences Recent Development
Table 106. InterGenetics Company Detail
Table 107. InterGenetics Business Overview
Table 108. InterGenetics Clinical Whole Exome Sequencing (WES) Product
Table 109. InterGenetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 110. InterGenetics Recent Development
Table 111. Genomics and Pathology Services (GPS) Company Detail
Table 112. Genomics and Pathology Services (GPS) Business Overview
Table 113. Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Product
Table 114. Genomics and Pathology Services (GPS) Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 115. Genomics and Pathology Services (GPS) Recent Development
Table 116. 3billion Company Detail
Table 117. 3billion Business Overview
Table 118. 3billion Clinical Whole Exome Sequencing (WES) Product
Table 119. 3billion Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 120. 3billion Recent Development
Table 121. Broad Genomic Company Detail
Table 122. Broad Genomic Business Overview
Table 123. Broad Genomic Clinical Whole Exome Sequencing (WES) Product
Table 124. Broad Genomic Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 125. Broad Genomic Recent Development
Table 126. Roche Company Detail
Table 127. Roche Business Overview
Table 128. Roche Clinical Whole Exome Sequencing (WES) Product
Table 129. Roche Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 130. Roche Recent Development
Table 131. Novogene Company Detail
Table 132. Novogene Business Overview
Table 133. Novogene Clinical Whole Exome Sequencing (WES) Product
Table 134. Novogene Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 135. Novogene Recent Development
Table 136. BGI Genomics Company Detail
Table 137. BGI Genomics Business Overview
Table 138. BGI Genomics Clinical Whole Exome Sequencing (WES) Product
Table 139. BGI Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 140. BGI Genomics Recent Development
Table 141. Shanghai Jingzhou Genomics Company Detail
Table 142. Shanghai Jingzhou Genomics Business Overview
Table 143. Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Product
Table 144. Shanghai Jingzhou Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 145. Shanghai Jingzhou Genomics Recent Development
Table 146. Shihe Gene Biotechnology Company Detail
Table 147. Shihe Gene Biotechnology Business Overview
Table 148. Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Product
Table 149. Shihe Gene Biotechnology Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 150. Shihe Gene Biotechnology Recent Development
Table 151. JUNO Genomics Company Detail
Table 152. JUNO Genomics Business Overview
Table 153. JUNO Genomics Clinical Whole Exome Sequencing (WES) Product
Table 154. JUNO Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 155. JUNO Genomics Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Whole Exome Sequencing (WES) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Clinical Whole Exome Sequencing (WES) Market Share by Type: 2022 VS 2033
Figure 3. Array-Based Exome Enrichment Features
Figure 4. Enrichment of the Exome in Solution using Biotinylated Probes Features
Figure 5. Global Clinical Whole Exome Sequencing (WES) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Clinical Whole Exome Sequencing (WES) Market Share by Application: 2022 VS 2033
Figure 7. Rare Genetic Disease Case Studies
Figure 8. Genetic Testing Unsuccessful Case Studies
Figure 9. Others Case Studies
Figure 10. Clinical Whole Exome Sequencing (WES) Report Years Considered
Figure 11. Global Clinical Whole Exome Sequencing (WES) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Clinical Whole Exome Sequencing (WES) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Clinical Whole Exome Sequencing (WES) Market Share by Region: 2022 VS 2033
Figure 14. Global Clinical Whole Exome Sequencing (WES) Market Share by Players in 2022
Figure 15. Global Top Clinical Whole Exome Sequencing (WES) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Whole Exome Sequencing (WES) as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Clinical Whole Exome Sequencing (WES) Revenue in 2022
Figure 17. North America Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Clinical Whole Exome Sequencing (WES) Market Share by Country (2018-2033)
Figure 19. United States Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Clinical Whole Exome Sequencing (WES) Market Share by Country (2018-2033)
Figure 23. Germany Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Share by Region (2018-2033)
Figure 31. China Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Clinical Whole Exome Sequencing (WES) Market Share by Country (2018-2033)
Figure 39. Mexico Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Share by Country (2018-2033)
Figure 43. Turkey Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. CentoXome Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 46. Mayo Clinic Laboratories Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 47. Baylor Genetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 48. Blueprint Genetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 49. GeneDx Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 50. CD Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 51. Illumina Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 52. Thermo Fisher Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 53. Labassure Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 54. Yale Medicine Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 55. Genosalut Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 56. Caris Life Sciences Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 57. InterGenetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 58. Genomics and Pathology Services (GPS) Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 59. 3billion Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 60. Broad Genomic Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 61. Roche Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 62. Novogene Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 63. BGI Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 64. Shanghai Jingzhou Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 65. Shihe Gene Biotechnology Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 66. JUNO Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed